financetom
Business
financetom
/
Business
/
Asian factories show tentative recovery as China improves
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Asian factories show tentative recovery as China improves
Sep 2, 2024 1:49 AM

TOKYO (Reuters) -Asian factories, including China's manufacturing sector, showed signs of a tentative recovery in August and chip makers benefitted from firm demand, private surveys showed on Monday, but economic headwinds loom.

Analysts say prospects of slowing U.S. growth, which is likely to lead to interest rate cuts by the Federal Reserve this month, and uncertainty over the outcome of the U.S. presidential election cloud the trade outlook.

China's Caixin/S&P Global manufacturing purchasing managers' index (PMI) rose to 50.4 in August from 49.8 in July, the private survey showed on Monday, beating analysts' forecasts and exceeding the 50 mark that separates growth from contraction.

The reading, which mostly covers smaller, export-oriented firms, shows a more optimistic view than an official PMI survey released on Saturday, which indicated an ongoing decline in manufacturing activity in August.

"The PMIs for August suggest that economic momentum held broadly steady last month, with modest improvements in manufacturing and services helping to offset a further slowdown in construction activity," Gabriel Ng, assistant economist at Capital Economics, said in a research note on China's PMI.

"But with factory gate price declines accelerating, the economy clearly remains at risk of slipping back into deflation," Ng said.

Factory activity in South Korea and Taiwan also expanded in August, while Japan saw a slower rate of contraction due in part to solid global demand for semiconductors.

Japanese manufacturers also gained from a rebound in car output after a safety scandal led some plants to temporarily suspend production.

But manufacturing activity contracted in Malaysia and Indonesia, the surveys showed, underscoring the pain some of the region's economies are facing from China's prolonged slowdown.

"Chip-producing countries are doing fairly well, but China's slowdown will continue to drag on Asia's manufacturing activity for quite some time," said Toru Nishihama, chief emerging market economist at Dai-ichi Life Research Institute.

"Slowing U.S. demand could add to the pain on Asian economies, many of which are already wary of the fallout from sluggish Chinese growth," he said.

Japan's final au Jibun Bank Japan manufacturing PMI rose to 49.8 in August, contracting for a second straight month but less sharply than in July when the index reached 49.1.

South Korea's PMI stood at 51.9 in August, up from 51.4 in July, due in part to strong customer confidence and new orders in the domestic market, the private survey showed.

Malaysia's PMI stood at 49.7 in August, flat from the previous month, while that of Indonesia fell to 48.9 from 49.3 in July, the surveys showed.

India's manufacturing activity growth eased to a three-month low in August as demand softened significantly, casting another shadow over the otherwise robust economic outlook.

The International Monetary Fund (IMF) anticipates a soft landing for Asia's economies as moderating inflation creates room for central banks to ease monetary policies to support growth. It predicts growth in the region to slow from 5% in 2023 to 4.5% this year and 4.3% in 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Merus Begins Phase 2 Trial of Colorectal Cancer Drug Candidate
Merus Begins Phase 2 Trial of Colorectal Cancer Drug Candidate
Jul 8, 2024
09:06 AM EDT, 07/08/2024 (MT Newswires) -- Merus (MRUS) said Monday it has dosed first patient in its phase 2 trial of petosemtamab combined with standard chemotherapy to treat second-line metastatic colorectal cancer. The open-label trial aims to evaluate the safety and preliminary antitumor activity of petosemtamab and chemotherapy in approximately 40 patients without prior EGFR inhibitor treatment. ...
Hungary's government seeks more corporate contributions, media funding limits
Hungary's government seeks more corporate contributions, media funding limits
Jul 8, 2024
* Hungary places measures in context of Ukraine war * Government has previously sought budget contributions * Plans to send back foreign funds given to Hungarian media * Orban met Xi on Monday, Putin on Friday (Updates throughout with media funding legislation; adds paragraphs 1-2, 6-9) By Boldizsar Gyori and Anita Komuves BUDAPEST, July 8 (Reuters) - Hungary's government laid...
Precision Drilling Extends Senior Credit Facility, Provides Update on 2024 Debt Repayment, Share Buyback
Precision Drilling Extends Senior Credit Facility, Provides Update on 2024 Debt Repayment, Share Buyback
Jul 8, 2024
09:06 AM EDT, 07/08/2024 (MT Newswires) -- Precision Drilling Corporation ( PDS ) has extended its senior credit facility and says it is on track to meet its 2024 debt reduction and share repurchase targets. The company extended its credit facility's maturity date to June 28, 2027, and revised the size to US$375 million (from US$447 million). The facility includes...
Eli Lilly Strikes $3.2 Billion Deal to Acquire Morphic
Eli Lilly Strikes $3.2 Billion Deal to Acquire Morphic
Jul 8, 2024
09:06 AM EDT, 07/08/2024 (MT Newswires) -- Eli Lilly ( LLY ) will buy biopharmaceutical company Morphic ( MORF ) for roughly $3.2 billion in a bid to expand its immunology portfolio with oral therapies targeting cell proteins for chronic diseases. The drugmaker will launch a tender offer to acquire all outstanding shares of Morphic ( MORF ) for $57...
Copyright 2023-2026 - www.financetom.com All Rights Reserved